Introduction Multi-agent neoadjuvant therapy (NAT) with immune checkpoint blockade is standard treatment for Stage II–III triple-negative breast cancer (TNBC), though its role in s
Cancer-related cognitive impairment (CRCI) is a multifaceted symptom associated with various comorbid conditions, complicating management. This study aims to evaluate cumulative sy